Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Sleep your way to a healthier brain? midlife sleep program aims to delay Alzheimer's

NCT ID NCT06311500

Prevention Sponsor: University of Kansas Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a 4-week sleep health program in 30 adults aged 45-64 to see if it could improve sleep and potentially delay Alzheimer's disease. Participants learned strategies to enhance their sleep health. The study measured how acceptable and effective the program was, using sleep trackers, questionnaires, and cognitive tests. It's an early step toward using sleep as a way to prevent Alzheimer's.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Sleep health enhancement intervention (behavioral: education and strategies)
What this could lead to
If successful, this approach could help improve sleep in midlife adults and potentially reduce the risk of Alzheimer's disease later in life.
What could go wrong
This is a small, early-phase study (30 participants) focused on feasibility and short-term effects. It does not directly test whether better sleep prevents Alzheimer's, and results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1/2

Runs two stages together: safety and dose first, then whether the treatment works.

Participants

30 people

The number who actually took part.

Started

Feb 2024

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

45 to 64 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 45-64 years old * ≤ 7 on the RU-SATED self-report questionnaire * MMSE ≥25 and AD8 \<3 Exclusion Criteria: * Known untreated sleep disorder (such as sleep apnea or restless leg syndrome) * \>3 on the STOP BANG indicating increased risk of sleep apnea * Increased risk of restless legs syndrome on RLS-Diagnosis Index * Evidence of circadian rhythm sleep-wake disorder * Evidence of parasomnia * Regular use (\>2x/week) of prescription or over-the-counter medications to improve sleep * Score of ≥15 on the Patient Health Questionnaire (PHQ-9) indicating severe depression or endorsement of any suicidal ideation (answer 1, 2 or 3 on #9 of the PHQ-9) * Score of ≥10 on the Generalized Anxiety Disorder (GAD-7) indicating moderate to severe anxiety * Self-report of current or history (up to 2 years) of drug or alcohol abuse based on the DSM-5-TR criteria * History of nervous system disorder such as stroke or Parkinson's disease * Severe mental illness such as schizophrenia or bipolar disorder * Current or history (within 5 years) of shift work including hours of midnight-4am * Is currently receiving a behavioral sleep health intervention

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Midlife adults are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Alzheimer disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Midlife adults Sleep health

Contacts and locations

Locations

  • University of Kansas Medical Center

    Kansas City, Kansas, 66160, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.